$200.00
Formula: C16H12FN3O3
ChemSpider ID: 3263
Pronunciation: /ˌfluːnɪˈtræzɪpæm/
Elimination half-life: 18–26 hours
Molar mass: 313.288 g·mol−1
Bioavailability: 64–77% (by mouth); 50% (suppository)
Metabolites: 7-aminoflunitrazepam, desmethylflunitrazepam and 3-hydroxydesmethylflunitrazepam
Rohypnol tablets contain flunitrazepam, a potent benzodiazepine with strong sedative and hypnotic effects. While it has been used in some countries for severe insomnia, it is heavily restricted or illegal in many regions due to safety concerns.
This guide provides a clear overview of Rohypnol tablets, including their medical background, effects, and important safety considerations.
Rohypnol is a central nervous system depressant that enhances the activity of GABA (gamma-aminobutyric acid), a neurotransmitter that slows brain activity.
Key points:
In limited medical settings (where permitted), flunitrazepam has been used for:
⚠️ Due to risks, safer alternatives are typically preferred today.
Rohypnol enhances GABA activity, leading to:
Reported effects may include:
Effects vary depending on dosage and individual response.
Common side effects may include:
Serious side effects require immediate medical attention.
Rohypnol carries significant safety risks, especially with misuse.
Always verify local laws and regulations.
Rohypnol tablets:
Consult a qualified healthcare provider for sleep-related concerns.
When dealing with sedative medications:
For sleep-related issues, consider:












